Abstract
Thirty human lung cancer cell lines were tested for chemosensitivity using the semi-automated, non-clonogenic MTT assay. The tumour cell lines came from three major categories of patients: untreated small cell lung cancer (SCLC); SCLC relapsing on chemotherapy; and non-SCLC predominantly from untreated patients. From these data IC50 values were derived for each drug in each cell line. While some inter-experimental variability was observed, the rank order of chemosensitivity of each cell line within this panel was significantly correlated between experiments. These results show that tumour cell lines derived from untreated small cell lung cancer patients were the most chemosensitive for adriamycin, melphalan, vincristine and VP16 compared to the other cell types. In addition, untreated SCLC was more sensitive than non-SCLC to BCNU and cis-platin, while vincristine was the only drug to which treated SCLC was more sensitive compared to the non-SCLC lines. In contrast, no significant differences between the lung cancer types were observed for vinblastine. Thus, this panel of lung cancer cells exhibited a drug sensitivity profile paralleling that observed in clinical practice. These results suggest that this lung cancer cell line panel in combination with a relatively simple but reproducible chemosensitivity assay, such as the MTT assay, has potential for the testing of drug combinations and evaluating new anti-cancer agents in vitro.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carmichael, J., Mitchell, J., DeGraff, W. et al. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer 57, 540–547 (1988). https://doi.org/10.1038/bjc.1988.125
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.125
This article is cited by
-
Dose-dependent autophagic effect of titanium dioxide nanoparticles in human HaCaT cells at non-cytotoxic levels
Journal of Nanobiotechnology (2016)
-
Down-regulation of microRNA-144 in air pollution-related lung cancer
Scientific Reports (2015)
-
In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species
World Journal of Microbiology and Biotechnology (2015)
-
Rapid assessment of drug response in cancer cells using microwell array and molecular imaging
Analytical and Bioanalytical Chemistry (2014)
-
Automated recognition of cell phenotypes in histology images based on membrane- and nuclei-targeting biomarkers
BMC Medical Imaging (2007)